EUDA Health Holdings Limited

EUDA

Medical - Care Facilities · Healthcare

Price

$13.21

-0.99 (-6.97%)

Market Cap

$24.7M

Exchange

NASDAQ Capital Market

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count rising — dilution

+301.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 463K (2021) → 1.9M (2025)

Winston Score History

The full picture

EUDA Health Holdings Limited is a small healthcare company based in Singapore that provides medical and wellness services to patients in Southeast Asia. Its core offerings include primary care clinics, mental health services, and digital health tools that connect patients with doctors. The company focuses on making healthcare more accessible in the region through a mix of in-person and technology-enabled care.

EUDA earns revenue by charging patients for clinic visits, medical consultations, and health management programs, with some recurring income from corporate wellness contracts. It operates primarily in Singapore and has been expanding its digital health platform across Southeast Asia. The company is quite small, with a market cap near zero, and its deeply negative operating margin signals it is spending significantly more than it earns. The main risk is whether EUDA can grow its patient base and revenue fast enough to reach profitability before running low on cash.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+548.6% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-496.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$249/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

49.6%ownership

Insiders own a meaningful stake in the company

Cash Runway

~0 months

$345,145 cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Revenue accelerating

EUDA Health Holdings Limited grew revenue 549% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

43.9%

Healthy — 43.9% gross margin

Profit after running costs

Operating Margin

-36.3%

Losing money on operations — -36.3%

Return on the money invested

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+193.2%

Fast-growing sales (+193.2% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-37.2%

Burning cash (-37.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

—

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial